Page last updated: 2024-10-31

metoclopramide and Vestibular Diseases

metoclopramide has been researched along with Vestibular Diseases in 1 studies

Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.

Vestibular Diseases: Pathological processes of the VESTIBULAR LABYRINTH which contains part of the balancing apparatus. Patients with vestibular diseases show instability and are at risk of frequent falls.

Research Excerpts

ExcerptRelevanceReference
"To assess and confirm the effect of ondansetron on behavior suggestive of nausea in dogs with vestibular syndrome."9.51Ondansetron in dogs with nausea associated with vestibular disease: A double-blinded, randomized placebo-controlled crossover study. ( Charalambous, M; Elliott, J; Foth, S; Henze, L; Kenward, H; Meller, S; Pelligand, L; Twele, F; Volk, HA, 2022)
"To assess and confirm the effect of ondansetron on behavior suggestive of nausea in dogs with vestibular syndrome."5.51Ondansetron in dogs with nausea associated with vestibular disease: A double-blinded, randomized placebo-controlled crossover study. ( Charalambous, M; Elliott, J; Foth, S; Henze, L; Kenward, H; Meller, S; Pelligand, L; Twele, F; Volk, HA, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Henze, L1
Foth, S1
Meller, S1
Twele, F1
Charalambous, M1
Kenward, H1
Elliott, J1
Pelligand, L1
Volk, HA1

Trials

1 trial available for metoclopramide and Vestibular Diseases

ArticleYear
Ondansetron in dogs with nausea associated with vestibular disease: A double-blinded, randomized placebo-controlled crossover study.
    Journal of veterinary internal medicine, 2022, Volume: 36, Issue:5

    Topics: Animals; Antiemetics; Arginine Vasopressin; Cross-Over Studies; Dog Diseases; Dogs; Double-Blind Met

2022